iParent2Parent Program for Parents of Children With Juvenile Idiopathic Arthritis

NCT04168034 | Completed DMC

• 1 other identifier: 1000061063
• Study Type: interventional
• Target: 6
• Locations: 1 country
• Sites: 2

Brief Summary

The iParent2Parent program matches parents of children living with arthritis with a trained parent mentor who will provide parents of children newly diagnosed with arthritis: practical coping advice and social support through shared lived experiences. This study will compare two groups of parents: those who are in the iParent2Parent program and those in the control group (no mentor).

Conditions

JIA

Outcome Measures

Primary Outcomes (1)

• Trial feasibility of iParent2Parent program

  Criteria for feasibility are based on studies previously conducted by our group and will be: accrual rate of \>70 percent, attrition rate of \<15percent, technical difficulties reported by \<10 percent of parents and mentors, adherence rate of \>80 percent, \<5 percent missed responses on outcome measures and high acceptability (based on qualitative analyses). Data related to the primary outcome will be recorded on investigator-developed forms.

  At study completion; an average of 2 years

Secondary Outcomes (4)

• PROMIS Adult Profile 25

  baseline; up to 12 weeks after baseline, 6 months post program

• Short form version of the PROMIS

  baseline; up to 12 weeks after baseline, 6 months post program

• Coping Health Inventory for Parents

  baseline; up to 12 weeks after baseline, 6 months post program

• Parental Stress Scale

  baseline; up to 12 weeks after baseline, 6 months post program

Study Arms (2)

Experimental: iParent2Parent Mentorship

EXPERIMENTAL

10 sessions of 20-30 minute Skype video calls conducted over 2 to 3 months

Behavioral: iParent2Parent Program

Waitlist Control Group

ACTIVE COMPARATOR

The control group will receive standard care but without the iParent2Parent program

Behavioral: Waitlist Control

Interventions

iParent2Parent Program BEHAVIORAL

In addition to standard care, parents in the experimental group will receive the iParent2Parent program. The iParent2Parent program is a tailored peer mentorship program that provides modeling and reinforcement by peers (trained parents of children with JIA) to parents of children diagnosed with JIA.

Experimental: iParent2Parent Mentorship

Waitlist Control BEHAVIORAL

The control group will receive standard care but without the iParent2Parent program

Waitlist Control Group

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• English speaking caregiver of a child diagnosed with JIA according to ILAR criteria prior to their 18th birthday
• Access to computer capable of using free Skype software

You may not qualify if:

• Significant cognitive impairment or major co-morbid illness of parent that impeded ability to engage in program (e.g.; psychosis, active suicidal ideation, cognitive delays that would impact ability to participate and complete questionnaires.)

Sponsors & Collaborators

• The Hospital for Sick Children: lead

Study Sites (2)

The IWK Health Centre

Halifax, Nova Scotia, B3K 6R8, Canada

Location

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

Study Officials

• Sara Ahola Kohut, PhD

  The Hospital for Sick Children

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Psychologist

Study Record Dates

• First Submitted: October 18, 2019
• First Posted: November 19, 2019
• Study Start: August 15, 2019
• Primary Completion: March 16, 2020
• Study Completion: March 16, 2020
• Last Updated: April 6, 2021

Record last verified: 2021-04

Data Sharing

• IPD Sharing: Will not share

Locations

CA (2)